Sky Medical develops bioelectronic medicine to prevent and treat acute and chronic circulatory conditions.
Sky Medical Technology is a growth-stage bioelectronic medicine platform that completely redefines the way vascular related conditions are treated. The company has developed a neuromodulation therapy called OnPulse™, the first clinically proven bioelectronic compression technology to prevent and treat a wide range of acute and chronic circulatory conditions. The first indications for the OnPulse wearable therapy are life threatening blood clots, swelling after orthopedic surgery, long term non-healing wounds, as well as applications for pro athletes to speed-up recovery time between games and during travel, conditions experienced by more than forty million people currently with unmet need.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 1, 2017 | Secondary Market | $16M | 1 | Barvest Ventures | — | Detail |
Sep 1, 2017 | Series B | $13.50M | 5 | Juno Capital Partners | — | Detail |
Jun 18, 2015 | Grant | $1.40M | 1 | Innovate UK | — | Detail |
Feb 1, 2015 | Series A | $15M | 4 | Deepbridge Capital Juno Capital Partners | — | Detail |
Feb 1, 2014 | Series Unknown | $13M | 4 | Juno Capital Partners Longbow Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Barvest Ventures | Yes | Secondary Market |
Juno Capital Partners | Yes | Series B |
Innovate UK | Yes | Grant |
Longbow Capital | Yes | Series Unknown |
Revera Home Health Business | — | Series B |
Baranco | — | Series B |
Deepbridge Capital | — | Series B |
Nissha Co., Ltd. | — | Series B |
Caliburn Capital | — | Series A |
Nigel Rudd | — | Series A |